Skip to Main Content

Jessica Tuan, MD, MS

Instructor of Medicine (Infectious Diseases); Affiliated Faculty, Yale Institute for Global Health

Research Summary

Dr. Tuan serves as Principal Investigator for research studies at the Yale School of Medicine: 1) Qualitative Assessment of SARS-CoV-2 Immunogenicity after COVID-19 vaccination in People Living with HIV study, 2) Real-World Utilization of Sotrovimab for COVID-19 study, 3) the NIH-funded AIDS Clinical Trials Group/National Institute of Allergy & Infectious Diseases Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (REPRIEVE) Clinical Trial, and 4) the upcoming Pfizer mRNA Influenza Vaccine clinical trial.

She serves as a Sub-Investigator for the Pfizer/BioNTech adult, pediatric, and booster COVID-19 vaccine and Sanofi COVID-19 vaccine clinical trials. She is a Sub-Investigator for the ongoing HIV clinical trials at the Yale University School of Medicine, including 1) Study to Evaluate the Safety & Efficacy of Broadly Neutralizing Antibodies in Combination with Lenacapavir, 2) Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administered every two months from a Bictegravir/emtricitabine/tenofovir alafenamide Single Tablet Regimen in Virologically Suppressed HIV-1 Infected Adults. Her recent research study focus is "Assessing Attitudes and Readiness for HIV Pre-exposure Prophylaxis (PrEP) among Adolescents & Young Women in Liberia."

Coauthors

Research Interests

HIV; Global Health; COVID-19

Selected Publications

Clinical Trials